P3 Health Valuation
| PIII Stock | USD 0.24 0.03 14.29% |
P3 Health seems to be undervalued based on Macroaxis valuation methodology. Our model determines the value of P3 Health Partners from reviewing the entity fundamentals such as shares owned by insiders of 23.20 %, and Return On Asset of -0.12 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting P3 Health's valuation include:
Price Book 0.2872 | Enterprise Value 116.2 M | Enterprise Value Ebitda (1.86) | Price Sales 0.0841 | Enterprise Value Revenue 0.0787 |
Undervalued
Today
Please note that P3 Health's price fluctuation is extremely dangerous at this time. Calculation of the real value of P3 Health Partners is based on 3 months time horizon. Increasing P3 Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since P3 Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PIII Stock. However, P3 Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.24 | Real 1.5 | Target 5.38 | Hype 0.21 |
The intrinsic value of P3 Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence P3 Health's stock price.
Estimating the potential upside or downside of P3 Health Partners helps investors to forecast how PIII stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of P3 Health more accurately as focusing exclusively on P3 Health's fundamentals will not take into account other important factors: When choosing an evaluation method for P3 Health Partners, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
P3 Health Cash |
|
PIII Valuation Trend
P3 Health's real value analysis enables investors to forecast the earnings more efficiently. Using both P3 Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
P3 Health Total Value Analysis
P3 Health Partners is at this time forecasted to have valuation of 116.24 M with market capitalization of 118.02 M, debt of 124.64 M, and cash on hands of 63.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the P3 Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
116.24 M | 118.02 M | 124.64 M | 63.15 M |
P3 Health Investor Information
About 23.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. P3 Health Partners recorded a loss per share of 0.86. The entity had not issued any dividends in recent years. Based on the key indicators obtained from P3 Health's historical financial statements, P3 Health Partners may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.P3 Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. P3 Health has an asset utilization ratio of 147.09 percent. This signifies that the Company is making $1.47 for each dollar of assets. An increasing asset utilization means that P3 Health Partners is more efficient with each dollar of assets it utilizes for everyday operations.P3 Health Ownership Allocation
P3 Health Partners secures a total of 162.86 Million outstanding shares. P3 Health Partners shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.P3 Health Profitability Analysis
The company reported the previous year's revenue of 1.27 B. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (7.75 M).About P3 Health Valuation
An absolute valuation paradigm, as applied to PIII Stock, attempts to find the value of P3 Health Partners based on its fundamental and basic technical indicators. By analyzing P3 Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of P3 Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of P3 Health. We calculate exposure to P3 Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of P3 Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 31.6 M | 33.2 M | |
| Pretax Profit Margin | (0.15) | (0.15) | |
| Operating Profit Margin | (0.13) | (0.14) | |
| Net Loss | (0.05) | (0.05) | |
| Gross Profit Margin | 0.02 | 0.02 |
P3 Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 294.6 M |
P3 Health Current Valuation Indicators
Valuation refers to the process of determining the present value of P3 Health Partners and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PIII we look at many different elements of the entity such as PIII's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as P3 Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use P3 Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes P3 Health's worth.Complementary Tools for PIII Stock analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |